Red Clover
Red Clover (Trifolium pratense)
Weak in vitro phytoestrogen activity; no human AGA evidence.
How Red Clover works — and how well we know it
Isoflavone content may have weak phytoestrogen / 5-AR-inhibitory activity in vitro. Topical formulations marketed by Vegamour and others.
topical, oral
Variable.
Dietary supplement. Contains isoflavones (biochanin A, formononetin) marketed as mild phytoestrogens.
Nothing AGA-specific.
Evidence distribution across 1 claims
Why the grade is F. In vitro signal only; no AGA RCT.
Every claim, traced back to its source
We took every major claim made about Red Clover and matched it to the specific experimental model behind it. Click a claim to see the model, the finding, and our assessment of how much weight it deserves.
1 claims · evidence-by-evidence breakdown
1In VitroWeight: LowWeak in vitro activity; no AGA RCTIn vitro only.
Cell culture studies of isoflavone activity.
Weak signal in vitro.
Has not translated to clinical AGA outcomes.
What's still missing from the science
- Human AGA trial.
Our verdict on Red Clover
Not in our formulary yet
We don't carry this ingredient. We only formulate around actives where the evidence — and the safety profile — is strong enough to recommend with confidence. As the data matures, we may revisit.
Related treatments
How does Red Clover stack up against its closest peers?
A genuine cause of reversible hair shedding in iron-deficient patients — but useless and potentially harmful if your iron stores are normal.
Read the breakdown →A botanical 5-alpha reductase inhibitor whose only high-quality trials (in BPH) showed no benefit over placebo; the positive AGA data are small and low-quality.
Read the breakdown →One small Malaysian RCT showed a hair-count increase. Never replicated. Used by Nutrafol to justify its tocotrienol content.
Read the breakdown →